1. Introduction {#s0005}
===============

Family Brassicaceae formerly known as Cruciferae, (cabbage family) is one of the most wide spread families in the plant kingdom ([@b0125]). Most members of Brassicaceae plants are of economical importance, such as cabbage, purple cabbage, cauliflower, broccoli and mustard, being either very common edible plants or important source for oil production from the seeds ([@b0040], [@b0105]). The edible plant *Sisymbrium irio* L., commonly known as London rocket, is a member of Brassicaceae family, widely distributed in different areas in Saudi Arabia ([@b0030]). It is an annual herb above three feet in height with open, slender stem branches and small pale yellow petals. The basal leaves are broad and often lobed, while the upper leaves are linear in shape and up to four inches long ([@b0085]). The Middle Eastern folk healers use the aerial parts of *S. irio* to detoxify liver and spleen, treat cough and chest congestion and rheumatism, reduce swelling and clean wounds ([@b0065]), while seeds are used as expectorant and in treatment of voice disorders ([@b0095]). *S. irio* is used for dietary purposes, and the leaves of the plant are frequently incorporated in salads and mixed with yogurt in certain recipes, by natives in some countries in the Mediterranean region ([@b0005]). Different extracts and isolated compounds from several species of this genus were also reported to have antipyretic, analgesic, antimicrobial and antioxidant activities ([@b0010], [@b0115]). Literature review revealed that genus *Sisymbrium* contains several classes of secondary metabolites such as flavonoids, alkaloids, anthraquinones, steroids and fatty acids ([@b0005], [@b0010], [@b0115]). It is well known that main volatile constituents of Brassicaceae plants, including genus *Sisymbrium*, are glucosinolate degradation products, mostly isothiocyanates (ITC) and nitriles, obtained by enzymatic and thermal degradation of glucosinolates. Contrary to intact glucosinolates, these breakdown products are responsible for various biological effects of Brassicaceae plants ([@b0025]). In fact, isothiocyanates and nitriles have been reported to have a broad-spectrum activity against fungal and bacterial pathogens, insects, nematodes and weeds ([@b0020]). However, the limited researches on *S. irio* encouraged us to investigate the chemical composition of its aerial parts and to evaluate the antibacterial and cytotoxic potentials of the *n*-hexane, dichloromethane, ethyl acetate and *n*-butanol fractions of the aforementioned plant. Additionally, we developed a simple and sensitive validated HPTLC method for quantification of biomarker, β-sitosterol glucoside, obtained as a major component from the biologically-active *n*-hexane fraction.

2. Materials and methods {#s0010}
========================

2.1. General experimental procedures {#s0015}
------------------------------------

Column chromatographic separations were performed on silica gel 60 (230--400 μm, Merck, Darmstadt, Germany). All chemicals and solvents were purchased from Sigma Chemical Company (St Louis, MO, USA). ^1^H and ^13^C NMR spectra were recorded on Bruker spectrometer at NMR Unit, College of Pharmacy, King Saud University operating at 500 and 125 MHz for ^1^H and ^13^C NMR, respectively. Resolution Mass Spectrophotometer was used for accurate mass determination. Electron Impact mode with ionization energy of 70 eV was accustomed.

2.2. Plant material {#s0020}
-------------------

The aerial parts of *S. irio* L. were collected from a local farm in Riyadh city located in Najd region in February 2015 and, kindly identified by a taxonomist at the Pharmacognosy Department, College of Pharmacy, King Saud University. A voucher specimen has been deposited in the herbarium of Pharmacognosy Department, College of Pharmacy.

2.3. Extraction, fractionation and isolation {#s0025}
--------------------------------------------

The air-dried powdered aerial parts of *S. irio* (250 g) were extracted by cold maceration with 85% ethanol till exhaustion. The ethanolic extract was dried in a rotary evaporator to give a dark residue (20 g). Subsequent fractions were obtained by dispersing the total ethanolic extract in 200 ml of distilled water followed by successive extraction with *n*-hexane, dichloromethane (DCM), ethyl acetate (EtOAc) and *n*-butanol (*n*-BuOH). All fractions were filtrated over anhydrous sodium sulfate and evaporated till dryness to yield fractions **A** (*n*-hexane, 2 g), **B** (DCM, 3.5 g), **C** (EtOAc, 2.5 g) and **D** (*n*-BuOH, 6.0 g). After comparing the results obtained from cytotoxicity and antibacterial for different fractions, part of fraction **A** (1 g) was subjected to silica gel column chromatography (100 g × 100 cm × 1.5 cm) using chloroform/methanol gradients to obtain seven subfractions (Si-1--7). Subfraction Si-3 was re-chromatographed on another silica gel column using chloroform/methanol in gradient mode of elution analysis. Fraction eluted by 2% MeOH afforded compounds **1** (50 mg) and **2** (30 mg) upon direct crystallization, while elution by 20% MeOH afforded compound **3** (60 mg).

2.4. Cytotoxic activity assay {#s0030}
-----------------------------

The cytotoxic activities, of the prepared fractions, were evaluated on three cancer cell lines (MCF-7, HCT-116 and HepG-2). The mammalian cell lines MCF-7 cells (human breast cancer), HepG-2 (human liver cancer) and HCT-116 (human colon cancer) were obtained from the American Type Culture Collection (ATCC). The cells were proliferated in Dulbecco's modified Eagle's Medium (DMEM) complemented with fetal bovine serum (10%), [l]{.smallcaps}-glutamine, HEPES buffer (1%) and gentamicin (50 μg/mL) (Sigma Chemical Co.). The cells were maintained with 5% CO~2~ at 37 °C and were subcultured two times a week.

The cytotoxic activity was assessed by the crystal violet staining (CVS) method ([@b0050], [@b0090]) using a 96-well tissue culture micro plate seeded with cells at concentration of 1 × 104 cells in 100 μL of medium per well. After 24 h, different concentrations of *S. irio* fractions (**A**--**D**), were added. Sequential set of dilutions of each fraction (100, 50, 25, 12.5, 6.25 and 3.125 μg) was added into a flat bottomed 96-well microtiter plates and incubated with 5%CO~2~ at 37 °C. Three wells were used for each concentration of the test sample. The control cells were incubated without a test sample and with or without DMSO. After 48 h, the media were removed and crystal violet solution (1%) was added to each well for 30 min. After that, the stain was removed by rinsing the plates with distilled water. For quantitative evaluation, the absorbance was measured in an automatic Microplate reader (TECAN, Inc., San Jose, CA, USA) at 595 nm for colorimetric estimation of fixed cells. The effect on cell growth was estimated by measuring the difference in absorbance percentage in the presence and absence of the tested fractions and presented in a dose-response curve. The concentration that inhibited cell growth by 50% (IC~50~) was obtained. Doxorubicin was used as standard antitumor drug.

2.5. Antibacterial activity assay {#s0035}
---------------------------------

To assess the antibacterial activity, four Gram positive (*Staphylococcus aureus*, *Staphylococcus epidermidis*, *Streptococcus pyogenes* and *Clostridium perfringens*) and four Gram negative bacteria (*Neisseria gonorrhoeae*, *Klebsiella pneumoni*, *Shigella flexner* and *Salmonella enteritidis*) were selected. The different strains of microbes were acquired from the American Type Culture Collection (ATCC).

The antibacterial activity was determined by agar well diffusion method performed in accordance with the National Committee Clinical Laboratory Standards (NCCLS) criteria ([@b0130], [@b0135]). Bacterial suspension was prepared at 0.5 McFarland standard turbulence in a volume of 100 μL and was cultivated on Mueller-Hinton agar media punched with 6-mm diameter wells. Then, 100 μl of 10% *S. irio* fractions was added to the wells, while 10% DMSO was used as the negative control. Ampicillin and gentamicin (30 μg/mL) were used as standard agents against the Gram positive bacteria and Gram negative bacteria, respectively. The antibacterial activity was estimated, after incubation of the plates at 37 °C for 18--24 h, by calculating the diameter of inhibition zones (mm). Each test was done three times and the mean of the results was determined.

2.6. Standardization of different fractions of S.irio by validated HPTLC method {#s0040}
-------------------------------------------------------------------------------

### 2.6.1. HPTLC instrumentation and conditions {#s0045}

A validated high-performance thin layer chromatography (HPTLC) method was used to standardize the total ethanolic extract, *n*-hexane, dichloromethane, ethyl acetate, and *n*-butanol fractions of *S. irio*. The chromatography was performed on 20 × 10 cm precoated silica gel F~254~ HPTLC plate, using β-sitosterol glucoside as the marker compound. Numerous combination of mobile phases was tried to get good separation and resolution of various compounds present in *S. irio*. Based on our observations, chloroform and methanol in the ratio of 16:4 were selected as mobile phase to accomplish the standardization. The marker along with different samples was applied by CAMAG automatic TLC sampler-4 on the HPTLC plate. CAMAG Automated Developing Chamber-2 was used to develop the HPTLC plate under controlled condition. The developed plate was dried and derivatized by spraying with p-anisaldehyde reagent and scanned by CAMAG TLC Scanner-3 (*λ* = 600 nm).

### 2.6.2. Preparation of standard stock solutions {#s0050}

Standard stock solution of β-sitosterol glucoside (1 mg/mL) was prepared in methanol, following further dilution with methanol to furnish different concentrations ranging from 10 to 90 μg/mL. All the dilutions were applied (10 μL, each) through microliter syringe attached with the applicator on the HPTLC plate to furnish the linearity range of 100--900 ng/band.

### 2.6.3. Validation of method {#s0055}

Validation of the proposed HPTLC method was performed according to the ICH guidelines ([@b0045]), for the determination of linearity range, limit of detection (LOD), limit of quantification (LOQ), precision, recovery as accuracy and robustness.

2.7. Statistical analysis {#s0060}
-------------------------

Data were expressed as means ± SD. The unpaired Student's *t*-test was conducted using the Graph Pad In Stat (ISI Software) computer program. Differences were considered significant at *P* values of less than 0.05.

3. Results {#s0065}
==========

3.1. Identification of isolated compounds {#s0070}
-----------------------------------------

The structures of the isolated compounds were elucidated by analyzing their spectroscopic data (1D, 2DNMR and MS) and by comparing these data with the literature as: β-sitosterol (**1**) ([@b0035]), stigmasterol (**2**) ([@b0060]) and β-sitosterol glucoside (**3**) ([@b0080]) ([Fig. 1](#f0005){ref-type="fig"}).Figure 1Chemical structures of isolated compounds from *S. irio*.

3.2. Biological studies {#s0075}
-----------------------

### 3.2.1. Cytotoxic activity {#s0080}

The cytotoxic activity was determined for the *n*-hexane, DCM, EtOAc and *n*-BuOH fractions (**A**--**D**) against HCT-116, MCF-7 and HepG-2 cancer cell lines, using the CVS method employing doxorubicin as a reference drug ([Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}, [Figure 4](#f0020){ref-type="fig"}). The IC~50~ was estimated for each cell line and results are shown in [Table 1](#t0005){ref-type="table"}.Figure 2Cytotoxicity assessment by CVS assay in HCT-116 tumor cell line. Values are the mean ± SE of three assays, *p* \< 0.01, compared to the reference drug.Figure 3Cytotoxicity assessment by CVS assay in MCF-7 tumor cell line. Values are the mean ± SE of three assays, *p* \< 0.01, compared to the reference drug.Figure 4Cytotoxicity assessment by CVS assay in HepG-2 tumor cell line. Values are the mean ± SE of three assays, *p* \< 0.01, compared to the reference drug.Table 1IC~50~[a](#tblfn1){ref-type="table-fn"} (μg/mL) of *S*. *irio* fractions on tested cell lines.Tumor cell line*n*-HexaneDCMEtOAc*n*-BuOHDoxorubicinHCT-11611.75.424619.80.47MCF-713.444.735.422.30.44HepG-213.323.235.8\>500.469[^1]

### 3.2.2. Antibacterial activity {#s0085}

The antibacterial activities for the obtained fractions (**A**--**D**) were evaluated, by determining their zone of inhibition, against four Gram-positive and four Gram-negative bacteria ([Table 2](#t0010){ref-type="table"}). The tested pathogenic bacteria are known to cause many serious diseases, ranging from simple skin infections to life-threatening systemic diseases including skin and respiratory infections and food poisoning.Table 2Antibacterial activities (mean zone of Inhibition, mm ± SD) of *S. irio* fractions against selected clinical pathogens.Tested microorganismsSample*n*-HexaneDCMEtOAc*n*-BuOHAmpicillin**Gram positive bacteria***Staphylococcus aureus* (RCMB 010027)21.3 ± 0.23NA18.3 ± 0.34NA28.9 ± 0.14*Staphylococcus epidermidis* (RCMB 010024)18.0 ± 0.13NA17.7 ± 0.16NA25.4 ± 0.18*Streptococcus pyogenes* (RCMB 010015)21.3 ± 0.15NA21.7 ± 0.32NA26.4 ± 0.34*Clostridium perfringens* (RCMB 010034)15.3 ± 0.32NA13.7 ± 0.14NA18.4 ± 0.34  **Gram negative bacteria**Gentamycin*Neisseria gonorrhoeae* (RCMB 010076)NANANANA19.9 ± 0.18*Klebsiella pneumoniae* (RCMB 0010093)17.7 ± 0.1112.3 ± 0.1221.0 ± 0.1116.0 ± 0.1026.3 ± 0.15*Shigella flexneri* (RCMB 0100542)16.7 ± 0.1412.7 ± 0.1618.3 ± 0.3115.3 ± 0.4124.8 ± 0.24*Salmonella enteritidis* (RCMB 010084)21.0 ± 0.2415.7 ± 0.2122.3 ± 0.1617.3 ± 0.1825.3 ± 0.18[^2]

3.3. Identification of β-sitosterol glucoside in different fractions of *S. irio* by validated HPTLC method {#s0090}
-----------------------------------------------------------------------------------------------------------

### 3.3.1. HPTLC method development and validation {#s0095}

The developed method was found to be very effective in clearly separating the biomarker β-sitosterol glucoside and different constituents of all the fractions of *S. irio* ([Fig. 5](#f0025){ref-type="fig"}). It was found to furnish an intense, compact and sharp peak of β-sitosterol glucoside at *R~f~* 0.43 ± 0.002 ([Fig. 6](#f0030){ref-type="fig"}). The optimized saturation time and mobile phase volume for saturation were found to be 20 min and 20 mL, respectively. The developed method was thus, found to be selective with high resolution baseline. The regression equation and correlation co-efficient (*r*^2^) for β-sitosterol glucoside were found to be *Y* = 9.518*x* + 885.57 and 0.9966 ± 0.0004 in the 100--900 ng/spot linearity range. The Limit of detection (LOD) and limit of quantification (LOQ) for β-sitosterol glucoside were found to be 21.84 and 66.18 ng/band, respectively ([Table 3](#t0015){ref-type="table"}). The % recovery of β-sitosterol glucoside was found to be 98.57--99.64% ([Table 4](#t0020){ref-type="table"}). The %RSD for Intra-day and inter-day precisions for β-sitosterol glucoside was found to be 0.465--0.587% and 0.425--0.548%, respectively. The standard error (SEM) for Intra-day and inter-day precisions was found to be 0.465--0.489 and 0.425--0.459, respectively ([Table 5](#t0025){ref-type="table"}). The SD and %RSD were found to be very less after deliberately modifying the mobile phase which confirmed that the method was highly robust ([Table 6](#t0030){ref-type="table"}).Figure 5Picture of the developed TLC plate derivatized with p-anisaldehyde reagent at daylight; mobile phase:chloroform:methanol (16:4).Figure 6Chromatogram of standard β-sitosterol glucoside (*R~f~* = 0.43; 500 ng/spot) at 600 nm; mobile phase:chloroform:methanol (16:4).Table 3*R~f~*, linear regression data for the calibration curve of β-sitosterol glucoside (*n* = 6).Parametersβ-sitosterol glucosideLinearity range (ng/spot)100--900Regression equation*Y* = 9.518*x* + 885.57Correlation (*r*^2^) coefficient0.9966 ± 0.0004Slope ± SD9.518 ± 0.062Intercept ± SD885.5 ± 13.77Standard error of slope0.0257Standard error of intercept5.623*R~f~*0.43 ± 0.002LOD21.84 ng/bandLOQ66.18 ng/bandTable 4Recovery as accuracy studies of the proposed HPTLC method (*n* = 6).Percent (%) of β-sitosterol glucoside added to analyteTheoretical concentration of β-sitosterol glucoside (ng/ml)Concentration of β-sitosterol glucoside found (ng/mL) *±* SD%RSDSEM%Recovery0200197.15 ± 1.5620.7920.63798.5750300297.38 ± 2.4390.8210.99599.12100400395.45 ± 3.6450.9211.48798.86150500498.21 ± 4.9510.9932.02199.64Table 5Precision of the proposed HPTLC method (*n* = 6).Conc. of β-sitosterol glucoside (ng/band)Intra-day precisionInter-day precisionAverage conc. found ± SD%RSDSEMAverage conc. found ± SD%RSDSEM400397.55 ± 1.8510.4650.755394.40 ± 1.6790.4250.685600598.86 ± 2.9310.4891.196591.50 ± 2.7180.4591.109800797.44 ± 3.8710.4851.581795.34 ± 3.6260.4561.480Table 6Robustness of the proposed HPTLC method (*n* = 6).Optimization conditionβ-sitosterol glucoside (300 ng/band)SD%RSDSEM*Mobile phase composition; (chloroform: methanol, v/v)*16:41.5260.5010.62215.8:4.21.5890.5230.64816.2:3.81.6850.5560.687  *Mobile phase volume (for saturation)*18 ml1.5060.4950.61420 ml1.5290.5040.62422 ml1.5850.5240.646  *Duration of saturation*10 min1.4960.4930.61020 min1.5170.5010.61930 min1.5350.5250.646

### 3.3.2. HPTLC analysis of β-sitosterol glucoside {#s0100}

The proposed validated HPTLC method was employed for quantitative analysis of β-sitosterol glucoside in *n*-hexane, dichloromethane, ethyl acetate, *n*-butanol fractions and total ethanolic extract of *S. irio* ([Fig. 7](#f0035){ref-type="fig"}). The biomarker β-sitosterol glucoside was found to be present in the *n*-hexane fraction ([Fig. 8](#f0040){ref-type="fig"}) while it was absent in the remaining fractions as well as the ethanolic extract. The dried *n*-hexane fraction of *S. irio* was found to contain 2.10 μg/mg of β-sitosterol glucoside. This is a maiden report, which demonstrated the development of an economical, precise, accurate and simple HPTLC method for quantitative analysis of β-sitosterol glucoside in different fractions of *S. irio*.Figure 73D display of all tracks at 600 nm; mobile phase:chloroform--methanol (16:4).Figure 8Chromatogram of *n*-hexane fraction scanned at 600 nm (β-sitosterol glucoside; *R~f~* = 0.43); mobile phase:chloroform--methanol (16:4).

4. Discussion {#s0105}
=============

The obtained compounds **1**--**3** are among the most spread phytosterols in the plant kingdom; β-sitosterol (**1**) and β -sitosterol glucoside (**3**) were isolated previously from *S. irio* ([@b0055]). On the other hand, stigmasterol (**2**) was reported from many plants belonging to family Brassicaceae, but, to the best of our knowledge, isolated here for the first time from *Sisymbrium.* It is well known that consuming plant-based diet rich in phytosterols can effectively reduce serum low density lipoprotein (LDL), and total cholesterol ([@b0075]). Additionally, β-sitosterol, and plants rich in it, are used as dietary supplements for symptomatic treatment of benign prostatic hypertrophy ([@b0140]).

According to the results shown in [Figure 2](#f0010){ref-type="fig"}, [Figure 3](#f0015){ref-type="fig"}, [Figure 4](#f0020){ref-type="fig"} and [Table 1](#t0005){ref-type="table"}, all fractions demonstrated a dose-dependent cytotoxic effect against the three tested cancer cell lines. However, the *n*-hexane fraction (A) showed the highest activities (IC~50~ = 11.7, 13.4 and 13.3 μg/mL) against HCT-116, MCF-7 and HepG-2, respectively. The DCM fraction (**B**) displayed remarkable cytotoxic activity against the HCT-116 cell line (IC~50~ = 5.4 μg/mL), while it exhibited less selective activity against the other two cell lines (IC~50~44.7 and 23.2 μg/mL). The EtOAc fraction was moderately active against all cell lines (IC~50~ = 35.4--46.0 μg/mL). On the other hand, the *n*-butanol fraction had low IC~50~ values (19.8 and 22.3 μg/mL) against HCT-116 and MCF-7 cell lines, respectively, but was totally inactive against HepG-2 cell line (IC~50~ \> 50 μg/mL).

The high activity observed for the *n*-hexane fraction can be attributed, in part, to its high content of hydrophobic compounds such as steroids, triterpenes, oils and fatty acids and their ability to penetrate cell membrane more easily ([@b0095]). Also, it was reported that β-sitosterol can disrupt the structure of cancer cell membranes and alter the signaling pathways that regulate tumor growth and apoptosis ([@b0120]). *In vivo* studies showed that adding β-sitosterol to diets of mice and rats fed with colon carcinogens decreased the proliferative changes of the tumor ([@b0015]).

*In vitro* antibacterial screening demonstrated various degrees of growth inhibition for the organic solvent fractions. Among the tested fractions, the maximum antibacterial activity was shown by the *n*-hexane and ethyl acetate fractions against the Gram positive bacteria *Streptococcus pyogenes* and the Gram negative bacteria *Salmonella enteritidis* (21.3--21.7 mm and 21.0--22.3 mm, diameter of zone of inhibition, respectively). *S. pyogenes* is the most common bacterial cause of pharyngitis, impetigo and serious skin infections involving deep layers such as erysipelas and cellulitis ([@b0110]), while *Salmonella* is one of the major diarrhea-causing bacteria ([@b0100]). Furthermore, the *n*-hexane exhibited high activity against the food poisoning bacteria *C. perfringens*, while both *n*-hexane and EtOAc fractions were moderately active against *S. aureus*, the most frequent cause of human skin and soft tissue abscesses ([@b0070]). However, DCM and *n*-BuOH fractions showed no growth inhibition for any of the tested Gram-positive bacteria. On the other hand, none of the tested fractions inhibited the growth of the Gram-negative bacteria *N. Gonorrhoeae* at 20 mg/mL.

The standardization of *n*-hexane, dichloromethane, ethyl acetate, *n*-butanol fractions and total ethanolic extract of *S. irio* by validated HPTLC method revealed the presence of anticancer biomarker β-sitosterol glucoside only in *n*-hexane fraction. This result validated the above finding of high cytotoxic and antibacterial activity of *n*-hexane fraction. Moreover, this method may also be applied to study the degradation kinetics of β-sitosterol glucoside and its determination in plasma and other biological fluids.

5. Conclusion {#s0110}
=============

The organic fractions obtained from the edible plant *S. irio* have powerful antibacterial and remarkable cytotoxic activities against the tested bacterial strains and cancer cell lines, respectively. Results revealed that both activities, mainly, reside in the *n*-hexane and ethyl acetate fractions, which can be potential sources of antibiotics and anticancer compounds. The plant is edible and rich in medicinally important bioactive metabolites e.g. flavonoids, phytosterols and unsaturated fatty acids. These facts make it highly nutritious component to integrate more frequently in our meals and also to be used in the production of health-promoting supplements. The applied HPTLC method was found to be very effective in quantification of the biomarker β-sitosterol glucoside present in the *n*-hexane fraction. The method can be used as a rational approach for the quality control of natural products in more scientific and efficacious way.
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[^1]: IC~50~: concentration of fraction required to reduce cell survival by 50%.

[^2]: NA: not active, data are expressed in the form of mean ± S.D.
